COMPANY PROFILE · UPDATED 18 NOV 2025

BigHat Biosciences

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The…

bighatbio.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2019
Headcount: 121
Open roles: 0
Last raised: Series B · Sign in to view

LEADERSHIP

Founders & key people

Theresa Tribble

Vice President at SynapDx

KytopenLandsdowne LabsBigHat BiosciencesThe EngineEverlyWellNebula IndustriesHarvard Business SchoolWellesley College

Mark DePristo

CEO at BigHat Biosciences

BigHat BiosciencesMirvieEverly HealthGoogleSynapDxBroad InstituteGoogleSynapDxBroad InstituteLEK Consulting

Peyton Greenside

Chief Officer at BigHat Biosciences

BigHat BiosciencesVALISSchmidt Science FellowsVerily Life SciencesBroad InstituteVALISSchmidt Science FellowsVerily Life SciencesBroad Institute

OPEN ROLES

Hiring at BigHat Biosciences

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$99,302,512

Investors

Andreessen Horowitz 8vcAME Cloud VenturesAmgenBristol-Myers Squibb CompanyGRIDS CapitalGaingelsInnovation EndeavorsQuadrille CapitalS32

Funding rounds

Series B
S32, AME Cloud Ventures, GRIDS Capital, Quadrille Capital, Bristol-Myers Squibb Company, Amgen, Andreessen Horowitz, 8VC, Gaingels
$75MJul 19, 2022
Series A
Andreessen Horowitz, 8VC, AME Cloud Ventures, Innovation Endeavors
$19MFeb 9, 2021
Seed
8VC
$5.3MDec 18, 2019